<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02495753</url>
  </required_header>
  <id_info>
    <org_study_id>201505127</org_study_id>
    <nct_id>NCT02495753</nct_id>
  </id_info>
  <brief_title>Vaginal Cleansing Before Cesarean Delivery to Reduce Infection</brief_title>
  <official_title>Vaginal Cleansing Before Cesarean Delivery to Reduce Infection: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the hypothesis that vaginal cleansing with
      povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean
      infectious morbidity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cesarean delivery is the most common surgical procedure performed on women in the US; nearly
      1.3 million are performed each year. Postoperative infectious morbidity is the most common
      complication of cesarean delivery. Post-cesarean infectious morbidity is often the result of
      indigenous vaginal flora that ascend into the uterus at the time of surgery. Thus, reducing
      vaginal microbial load may reduce post-cesarean infection. However, results from studies
      assessing the role of vaginal cleansing prior to cesarean have been mixed.

      The investigators will perform a randomized controlled clinical trial to test the hypothesis
      that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery
      reduces postcesarean infectious morbidity.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Postoperative Infectious Morbidity</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Maternal fever, endometritis, intrabdominal infection or abscess, wound complication within 30 days of delivery or wound infection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Reaction to Vaginal Cleansing</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Hypersensitivity Reaction or more severe allergic reaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Days in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of readmissions to hospital for infectious morbidity.</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Number of times patient is readdmitted for any infectious morbidity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment for neonatal Sepsis</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Any antibioitics given for neonate with suspected sepsis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of outpatient visits for infectious morbidiy.</measure>
    <time_frame>30 days postoperatively.</time_frame>
    <description>Number of outpatient or emergency room visits related to infectious morbidity.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Prespecified Stratified Analysis for Subgroups</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Planned secondary analysis will be aimed at obtaining adjusted assessments of treatment effectiveness with interaction tests used to determine if the effectiveness of vaginal cleansing differs across subgroups. Subgroups include BMI categories, rupture status, chorioamnionitis, stage of labor, cervical dilation &gt;6 cm, gestational age, use of monitors, time in labor, duration of rupture, presence of GBS, labor status, and use of ripening agents.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">608</enrollment>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Abdominal and Vaginal Cleansing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the treatment arm, the vagina will be cleansed prior to usual abdominal cleansing before cesarean section.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdominal Cleansing Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the control arm, abdominal cleansing will be performed per routine with no vaginal cleansing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vaginal Cleansing</intervention_name>
    <description>The vagina will be prepped in two passes with sponge sticks soaked in 1% povidone-iodine solution from a prepackaged sterile pouch.</description>
    <arm_group_label>Abdominal and Vaginal Cleansing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominal Cleansing</intervention_name>
    <description>The abdomen will be cleansed using chlorhexidine or betadine according to surgeon's preference prior to cesarean.</description>
    <arm_group_label>Abdominal and Vaginal Cleansing</arm_group_label>
    <arm_group_label>Abdominal Cleansing Alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing cesarean delivery after labor at Barnes-Jewish Hospital.

        Exclusion Criteria:

          -  Inability to obtain consent

          -  known or suspected allergy to iodine or shellfish

          -  women with active herpes simplex virus infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antonina I Frolova, MD</last_name>
    <phone>314-362-7300</phone>
    <email>frolovaa@wudosis.wustl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonina I Frolova, MD</last_name>
      <phone>314-362-7300</phone>
      <email>frolovaa@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Alison G Cahill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorene A Temming, MD</last_name>
      <phone>314-362-7300</phone>
      <email>temmingl@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Lorene A Temming, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2015</study_first_submitted>
  <study_first_submitted_qc>July 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2015</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>wound infection</keyword>
  <keyword>vaginal cleansing</keyword>
  <keyword>endometritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

